Wire Stories
-
692GLIDE: Vaccination Incentives and Next Generation Sequencing � Two Pakistani Doctors Employ Innovative Techniques to Eradicate Polio
? Dr Jai Das and Dr Muhammad Salman selected to receive a Falcon Award for Disease Elimination ? They will each receive...
-
712
Cyril Amarchand Mangaldas announces the opening of its Singapore Foreign Law Practice
MUMBAI–(BUSINESS WIRE)–#CAM–India�s leading law firm, Cyril Amarchand Mangaldas (CAM) announced today the opening of its new foreign law practice in Singapore, Cyril...
-
639
SOPA 2022 Journalism Awards Open for Entries; Deadline 17 Feb
HONG KONG–(BUSINESS WIRE)–#SOPAwards2022–The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to the pursuit of excellence in journalism, announced today...
-
582
Murata and Michelin Co-develop RFID Module to Improve Tire Management Operations
Michelin co-develops RFID module to improve tire management operations KYOTO, Japan–(BUSINESS WIRE)–Murata Manufacturing Co., Ltd. (TOKYO:6981) (ISIN:JP3914400001) has co-developed a new generation...
-
569
KOREA PACK & ICPI WEEK (Int�l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
GOYANG, South Korea–(BUSINESS WIRE)–#BioPharmaExhibition–KOREA PACK and concurrent event ICPI WEEK (Int�l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events...
-
566
Confluent and Alibaba Cloud Announce Partnership to set Data in Motion in Mainland China
SINGAPORE–(BUSINESS WIRE)–Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba...
-
650
GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor
? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon Award for Disease Elimination ? She will...
-
635
Understanding the Hehe Culture and A Community of Shared Future for Mankind in Taizhou, Zhejiang
TAIZHOU, China–(BUSINESS WIRE)–Themed �Hehe Culture and A Community of Shared Future for Mankind�, the 2021 Hehe Culture Global Forum was held in...
-
1.1K
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting
BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with chronic lymphocytic leukemia Consistent efficacy was observed...
-
848
Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory ATL Orphan Drug Designation granted with regulatory...
